Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schizophrenia
|
2897 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2011 | 2018 | ||||||
Carcinoma of lung
|
1204 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Glioma
|
353 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of lung
|
1142 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Polycystic Ovary Syndrome
|
363 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.090 | 0.444 | 9 | 2007 | 2017 | ||||||
Cardiovascular Diseases
|
711 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.060 | 0.833 | 6 | 2008 | 2017 | ||||||
Impaired glucose tolerance
|
81 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.040 | 0.750 | 4 | 2006 | 2017 | ||||||
Prediabetes syndrome
|
16 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
Cholangiocarcinoma
|
43 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
elevated blood glucose level
|
111 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Glucose measurement
|
111 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Myocardial Ischemia
|
103 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Physical Activity Measurement
|
355 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Smoking
|
765 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||
Malignant Neoplasms
|
1641 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Primary malignant neoplasm
|
1374 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Malignant neoplasm of stomach
|
615 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Stomach Carcinoma
|
652 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Diabetic Retinopathy
|
213 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2014 | 2015 | ||||||
Hypertriglyceridemia
|
169 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||||
Dyslipidemias
|
184 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Hepatitis C
|
347 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Hereditary Multiple Exostoses
|
51 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Hip circumference
|
116 | 0.554 | 0.680 | 10 | 112998590 | intron variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2015 | 2015 |